EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

(2011) E. Doubrovina et al.   BLOOD

Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation

(2011) Austen Worth et al.   BRITISH JOURNAL OF HAEMATOLOGY

The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation

(2011) Maud D'Aveni et al.   TRANSPLANT IMMUNOLOGY

Rituximab Treatment for Epstein-Barr Virus DNAemia after Alternative-Donor Hematopoietic Stem Cell Transplantation

(2010) Stefania Coppoletta et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

(2010) J. N. Barker et al.   BLOOD

Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation

(2010) Ben Carpenter et al.   TRANSPLANTATION

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

(2009) O. Landgren et al.   BLOOD

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction

(2009) H. Omar et al.   Transplant Infectious Disease

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

(2009) J. Styczynski et al.   Transplant Infectious Disease

Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation

(2009) Imran Ahmad et al.   TRANSPLANTATION

Post-transplant lymphoproliferative disease following reduced intensity conditioning transplants incorporating alemtuzumab

(2008) S W Bokhari et al.   BONE MARROW TRANSPLANTATION

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

(2008) J Styczynski et al.   BONE MARROW TRANSPLANTATION